Mexico's Cannabis Debate Shifts to Harm Reduction Amid Regulatory Gaps
Translated from Spanish, summarized and contextualized by DistantNews.
At a glance
- Mexico faces a paradox: the Supreme Court decriminalized recreational cannabis, but the country lacks a comprehensive regulatory framework for its production and sale.
- Experts argue that shifting the focus from prohibition to harm reduction, through clear regulations on THC content, quality control, and public health information, is essential.
- Countries like Canada and Uruguay offer lessons in regulating cannabis, emphasizing public health and safety alongside market control, which Mexico needs to adopt.
Mexico's approach to cannabis policy is at a crossroads, moving away from absolute prohibition but struggling to establish a modern regulatory framework. The Supreme Court has decriminalized recreational use, yet a comprehensive system for production, transformation, and commercialization remains absent.
The debate on cannabis must change its focus: the challenge is not only to decide on its consumption, but to establish public policies capable of reducing its risks and protecting health when consumption exists.
Advocates argue that the debate must shift from simply deciding on consumption to implementing public policies that reduce risks and protect health. This harm reduction approach doesn't promote use but aims to mitigate dangers through information, prevention, controlled products, and evidence-based decisions. Key to this is ensuring consumers know the THC content, understand production methods, and can trust that products are free from contaminants like pesticides and heavy metals.
International examples highlight the path forward. Canada's 2018 regulation of adult-use cannabis was framed as a public health and safety policy, focusing on protecting minors, controlling quality, curbing the illegal market, and informing consumers. Uruguay's experience also demonstrates that regulation provides tools to measure and correct market effects over time.
Knowing how much THC a product contains, how it was produced, and whether it is free of contaminants is not a luxury: it is a basic condition of public health.
Despite these lessons, Mexico faces a fragmented market. While COFEPRIS allows some self-consumption-related activities, a general authorization for commercialization and distribution is missing. This leaves consumers, producers, and investors in a state of uncertainty, lacking sufficient rules to build a formal value chain. Implementing a modern regulatory framework is presented as a crucial step for public health and market development.
Regulation does not mean ending the debate; it means having tools to measure and correct it.
Originally published by El Universal in Spanish. Translated, summarized, and contextualized by our editorial team with added local perspective. Read our editorial standards.